Inventor · disambiguated record
Guy M. Miller
Also filed as: MILLER GUY · MILLER GUY M · MILLER GUY MICHAEL
27 granted patents·54 pending applications·920 citations·filing 1996–2022
97Inventor score
Files withMILLER GUY M17EDISON PHARMACEUTICALS INC13BIOELECTRON TECH CORP12PTC THERAPEUTICS INC7GALILEO PHARMACEUTICALS INC6
Top patents by PatentIndex Score
81 records- 0198US9399612B2Treatment of pervasive developmental disorders with redox-active therapeuticsEDISON PHARMACEUTICALS INC·Filed 2015·Granted Jul 26, 2016·12 cites·11 claims
- 0298US8653144B2Treatment of pervasive developmental disorders with redox-active therapeuticsEDISON PHARMACEUTICALS INC·Filed 2012·Granted Feb 18, 2014·32 cites·31 claims
- 0397US6426362B1Formulations of tocopherols and methods of making and using themGALILEO LAB INC·Filed 2000·Granted Jul 30, 2002·161 cites·22 claims
- 0496US8314153B2Treatment of pervasive developmental disorders with redox-active therapeuticsMILLER GUY M·Filed 2009·Granted Nov 20, 2012·51 cites·24 claims
- 0596US7432305B2Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkersEDISON PHARMACEUTICALS INC·Filed 2006·Granted Oct 7, 2008·60 cites·21 claims
- 0695US6900218B2Pyruvate derivativesGALILEO PHARMACEUTICALS INC·Filed 2002·Granted May 31, 2005·47 cites·4 claims
- 0795US6528042B1Compositions of flavonoids for use as cytoprotectants and methods of making and using themGALILEO LAB INC·Filed 2000·Granted Mar 4, 2003·107 cites·22 claims
- 0894US9370496B2Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinonesEDISON PHARMACEUTICALS INC·Filed 2013·Granted Jun 21, 2016·20 cites·16 claims
- 0994US7034054B2Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherolsGALILEO PHARMACEUTICALS INC·Filed 2001·Granted Apr 25, 2006·50 cites·43 claims
- 1092US10105325B2Treatment of pervasive developmental disorders with redox-active therapeuticsBIOELECTRON TECH CORP·Filed 2016·Granted Oct 23, 2018·4 cites·20 claims
- 1191US9278085B2Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkersMILLER GUY M·Filed 2007·Granted Mar 8, 2016·19 cites·14 claims
- 1290US8969420B2Treatment of pervasive developmental disorders with redox-active therapeuticsEDISON PHARMACEUTICALS INC·Filed 2014·Granted Mar 3, 2015·9 cites·22 claims
- 1389US7491312B2Identifying therapeutic compounds based on their physical-chemical propertiesEDISON PHARMACEUTICALS INC·Filed 2003·Granted Feb 17, 2009·47 cites·30 claims
- 1489US7119117B2Tocopherol enriched compositions and amelioration of inflammatory symptomsGALILEO PHARMACEUTICALS INC·Filed 2002·Granted Oct 10, 2006·48 cites·17 claims
- 1589US5801159AMethod and composition for inhibiting cellular irreversible changes due to stressGALILEO LAB INC·Filed 1996·Granted Sep 1, 1998·131 cites·20 claims
- 1686US9447006B2Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkersMILLER GUY M·Filed 2006·Granted Sep 20, 2016·7 cites·53 claims
- 1781US9932286B2Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkersBIOELECTRON TECH CORP·Filed 2015·Granted Apr 3, 2018·3 cites·8 claims
- 1880US6916850B2Pyruvate derivativesGALILEO PHARMACEUTICALS INC·Filed 2002·Granted Jul 12, 2005·5 cites·60 claims
- 1979US7629375B2Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methodsJOHNSON & JOHNSON CONSUMER·Filed 2004·Granted Dec 8, 2009·9 cites·9 claims
- 2079US7081476B2Tocopherol enriched compositions for reducing IL6 levelsGALILEO PHARMACEUTICALS INC·Filed 2005·Granted Jul 25, 2006·5 cites·20 claims
- 2177US6750247B2Sponge-derived terpenoids and methods of useUNIV CALIFORNIA·Filed 2002·Granted Jun 15, 2004·13 cites·9 claims
- 2276US6232060B1Assay system for anti-stress agentsGALILEO LAB INC·Filed 1996·Granted May 15, 2001·78 cites·10 claims
- 2375US10736857B2Treatment of pervasive developmental disorders with redox-active therapeuticsPTC THERAPEUTICS INC·Filed 2018·Granted Aug 11, 2020·0 cites·20 claims
- 2474US10195161B2Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinonesBIOELECTRON TECH CORP·Filed 2016·Granted Feb 5, 2019·1 cites·22 claims
- 2574US2022055975A1Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkersPTC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2674US2021128494A1Treatment of pervasive developmental disorders with redox-active therapeuticsPTC THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2773US2022133648A1Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinonesPTC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2870US2023335287A1Systems and methods for measuring, learning, and using emergent properties of complex adaptive systemsEMERJA CORP·Filed 2021·Application pending·0 cites
- 2968US10039722B2Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cellsMILLER GUY M·Filed 2009·Granted Aug 7, 2018·0 cites·13 claims
- 3068US2021322337A1Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cellsPTC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3167US2021145769A1Treatment of methylmalonic aciduria, isovaleric aciduria, and other organic acidurias with tocotrienol quinonesPTC THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3265US7737179B2Methods for treatment of dermatological conditionsJ & J CONSUMER COMPANIES INC·Filed 2004·Granted Jun 15, 2010·1 cites·4 claims
- 3364US2025073184A1Cannabigeroquinone compounds, compositions including such compounds, and uses of such compounds and compositionsJUVA LIFE INC·Filed 2022·Application pending·0 cites
- 3464US2010029784A1Naphthoquinone compositions with anti-aging, anti-inflammatory and skin even-toning propertiesHINMAN ANDREW W·Filed 2009·Application pending·0 cites
- 3564US2010029706A1HYDROGENATED PYRIDO[4,3-b]INDOLES FOR THE TREATMENT OF OXIDATIVE STRESSEDISON PARMACEUTICALS INC A DE·Filed 2009·Application pending·0 cites
- 3663US2011046156A1Treatment of hearing and balance impairments with redox-active therapeuticsMILLER GUY M·Filed 2009·Application pending·0 cites
- 3763US2010010100A1Dermatological compositions with anti-aging and skin even-toning propertiesHINMAN ANDREW W·Filed 2009·Application pending·0 cites
- 3863US2025057859A1Cannabichromenequinone and analogues thereof, and method of using compositions thereof as anti-inflammatory agentsJUVA LIFE INC·Filed 2022·Application pending·0 cites
- 3961US2013267538A1Treatment of mitochondrial diseasesAMPERE LIFE SCIENCES INC·Filed 2013·Application pending·0 cites
- 4061US2015057363A1Treatment of methylmalonic aciduria, isovaleric aciduria, and other organic acidurias with tocotrienol quinonesMILLER GUY M·Filed 2012·Application pending·0 cites
- 4160US2009163529A1Identifying therapeutic compounds based on their physical-chemical propertiesEDISON PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 4260US2009162890A1Identifying therapeutic compounds based on their physical-chemical propertiesEDISON PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 4360US2022257533A1Methods and compositions for treatment of inflammation and oxidative stressPTC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4459US2016324823A1Treatment of mitochondrial diseasesAMPERE LIFE SCIENCES INC·Filed 2016·Application pending·0 cites
- 4558US11021424B2Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkersMILLER GUY M·Filed 2010·Granted Jun 1, 2021·0 cites·85 claims
- 4658US2019216749A1Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinonesBIOELECTRON TECH CORP·Filed 2018·Application pending·0 cites
- 4757US2018303770A1Treatment of methylmalonic aciduria, isovaleric aciduria, and other organic acidurias with tocotrienol quinonesDIONISI VICI CARLO·Filed 2018·Application pending·0 cites
- 4857US2014249160A1Treatment of hearing and balance impairments with redox-active therapeuticsEDISON PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4957US2006178356A1Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methodsGALILEO PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 5056US2018303767A1Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cellsBIOELECTRON TECH CORP·Filed 2018·Application pending·0 cites
Showing the top 50 of 81 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Guy M. Miller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →